Post-transplantation lymphoproliferative disorders: Current concepts and future therapeutic approaches

doi:10.5500/wjt.v10.i2.29

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (15115)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-3) series.

Item

Count

PDF

955

WORD

191

HTML

11228

Figures (1-8)

687

Tables (1-3)

386

Sum=13447

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

768

Download

900

Sum=1668

Feb 28, 2020 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (60)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Transplant. Feb 28, 2020; 10(2): 29-46
Published online Feb 28, 2020. doi: 10.5500/wjt.v10.i2.29

Full Size Figure Download Figure

Figure 4 Epstein-Barr virus positivity among various types of post-transplant lymphoproliferative disorders[4]. EBV: Epstein-Barr virus.

Citation: Abbas F, El Kossi M, Shaheen IS, Sharma A, Halawa A. Post-transplantation lymphoproliferative disorders: Current concepts and future therapeutic approaches. World J Transplant 2020; 10(2): 29-46
URL: https://www.wjgnet.com/2220-3230/full/v10/i2/29.htm
DOI: https://dx.doi.org/10.5500/wjt.v10.i2.29